The Antagonism between the Murine Gammaherpesvirus Protein Kinase and Global Interferon Regulatory Factor 1 Expression Shapes the Establishment of Chronic Infection.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
26 10 2022
Historique:
pubmed: 29 9 2022
medline: 29 10 2022
entrez: 28 9 2022
Statut: ppublish

Résumé

Gammaherpesviruses infect most vertebrate species and are associated with B cell lymphomas. Manipulation of B cell differentiation is critical for natural infection and lymphomagenesis driven by gammaherpesviruses. Specifically, human Epstein-Barr virus (EBV) and murine gammaherpesvirus 68 (MHV68) drive differentiation of infected naive B cells into the germinal center to achieve exponential increase in the latent viral reservoir during the establishment of chronic infection. Infected germinal center B cells are also the target of viral lymphomagenesis, as most EBV-positive B cell lymphomas bear the signature of the germinal center response. All gammaherpesviruses encode a protein kinase, which, in the case of Kaposi's sarcoma-associated herpesvirus (KSHV) and MHV68, is sufficient and necessary, respectively, to drive B cell differentiation

Identifiants

pubmed: 36169331
doi: 10.1128/jvi.01260-22
pmc: PMC9599343
doi:

Substances chimiques

Interferon Regulatory Factor-1 0
Protein Kinases EC 2.7.-
Antiviral Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0126022

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI165578
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA203923
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM080202
Pays : United States

Références

J Virol. 2013 Jul;87(14):8038-52
pubmed: 23678174
PLoS Pathog. 2014 Aug 28;10(8):e1004307
pubmed: 25166506
J Virol. 2007 May;81(10):5407-12
pubmed: 17360761
Nature. 2014 Jan 30;505(7485):691-5
pubmed: 24284630
J Virol. 2016 Dec 16;91(1):
pubmed: 27795415
J Immunol. 2003 Apr 1;170(7):3828-34
pubmed: 12646650
J Virol. 2000 Apr;74(7):3093-104
pubmed: 10708424
Viral Immunol. 2020 May;33(4):316-326
pubmed: 31913773
Nature. 2011 Apr 28;472(7344):481-5
pubmed: 21478870
J Clin Invest. 2018 Jun 1;128(6):2519-2534
pubmed: 29733294
J Gen Virol. 1990 Jun;71 ( Pt 6):1365-72
pubmed: 2161903
mBio. 2021 Apr 6;12(2):
pubmed: 33824206
J Virol. 2012 Jun;86(12):6899-912
pubmed: 22496235
Virology. 2011 Nov 25;420(2):73-81
pubmed: 21943826
Cell Host Microbe. 2007 Jun 14;1(4):275-86
pubmed: 18005708
Annu Rev Pathol. 2014;9:349-72
pubmed: 24111911
PLoS Pathog. 2010 Sep 09;6(9):e1001092
pubmed: 20838604
J Immunol. 2006 Feb 1;176(3):1741-9
pubmed: 16424204
J Virol. 2012 Dec;86(23):12655-64
pubmed: 22973039
Nature. 2004 Dec 2;432(7017):635-9
pubmed: 15577913
J Virol. 1997 Aug;71(8):5894-904
pubmed: 9223479
J Biol Chem. 1999 Jun 25;274(26):18470-6
pubmed: 10373455
J Clin Microbiol. 1983 Apr;17(4):619-24
pubmed: 6304142
Leuk Res. 2009 Oct;33(10):1308-12
pubmed: 19345417
J Virol. 2019 Apr 3;93(8):
pubmed: 30728267
Virology. 2010 Sep 15;405(1):50-61
pubmed: 20557919
Cell. 1988 Sep 9;54(6):903-13
pubmed: 3409321
J Virol. 2008 Dec;82(23):11913-26
pubmed: 18815303
Science. 1994 Jun 24;264(5167):1921-4
pubmed: 8009222
J Gen Virol. 1990 Jun;71 ( Pt 6):1355-64
pubmed: 2351958
PLoS Pathog. 2011 Sep;7(9):e1002230
pubmed: 21909274
Virology. 2010 Jan 20;396(2):323-8
pubmed: 19910013
Cell Rep. 2021 Mar 23;34(12):108891
pubmed: 33761354
J Virol. 2008 Sep;82(17):8500-8
pubmed: 18562537
J Virol. 2021 Aug 10;95(17):e0085921
pubmed: 34132573
PLoS Pathog. 2014 May 01;10(5):e1004106
pubmed: 24789087
Cell. 1993 Oct 8;75(1):83-97
pubmed: 8402903
PLoS Pathog. 2009 Nov;5(11):e1000677
pubmed: 19956661
Virology. 2013 Aug 15;443(1):123-33
pubmed: 23706314
Ann Epidemiol. 2001 Oct;11(7):512-8
pubmed: 11557184
PLoS One. 2012;7(3):e33230
pubmed: 22427999
J Virol. 2015 Dec 30;90(6):2818-29
pubmed: 26719266
J Immunol. 2000 Feb 15;164(4):1820-8
pubmed: 10657630
J Virol. 2021 Sep 27;95(20):e0072621
pubmed: 34346769
Nature. 2002 Feb 14;415(6873):802-6
pubmed: 11823785
J Virol. 2009 Apr;83(8):3968-76
pubmed: 19193789
J Virol. 2009 Feb;83(4):1856-69
pubmed: 19052084
Immunity. 2000 Oct;13(4):539-48
pubmed: 11070172
Viruses. 2014 Nov 04;6(11):4178-94
pubmed: 25375883
J Virol. 2021 Apr 12;95(9):
pubmed: 33597211
N Engl J Med. 2004 Mar 25;350(13):1328-37
pubmed: 15044644
Cell Host Microbe. 2011 Oct 20;10(4):390-400
pubmed: 22018239
Nat Rev Immunol. 2001 Oct;1(1):75-82
pubmed: 11905817
Virology. 2016 May;492:140-4
pubmed: 26945150
PLoS Pathog. 2014 Jul 31;10(7):e1004269
pubmed: 25079788
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4239-44
pubmed: 22371602
Cell Host Microbe. 2009 Feb 19;5(2):166-78
pubmed: 19218087
J Exp Med. 2002 Nov 18;196(10):1363-72
pubmed: 12438427
J Virol. 2012 Nov;86(22):12330-40
pubmed: 22951828
J Virol. 1999 Apr;73(4):3273-83
pubmed: 10074181
J Virol. 2006 Jun;80(11):5125-34
pubmed: 16698993
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3146-51
pubmed: 24516154
J Virol. 2014 Jun;88(12):6993-7004
pubmed: 24719409
J Virol. 2012 Apr;86(7):3916-23
pubmed: 22278234
Cancer Res. 2009 Jul 15;69(14):5681-9
pubmed: 19584288
Arch Virol. 1999;144(1):157-66
pubmed: 10076516
Immunology. 2013 Jun;139(2):197-204
pubmed: 23311955

Auteurs

C N Jondle (CN)

Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

P A Sylvester (PA)

Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

D L Schmalzriedt (DL)

Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

K Njoya (K)

Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

V L Tarakanova (VL)

Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH